Glaxo (GSK) Beats on Q4 Earnings, to Focus on Oncology in '19

GlaxoSmithKline plc GSK reported adjusted earnings of 79 cents per American depositary share (“ADS”) for the fourth quarter of 2018, which beat the Zacks Consensus Estimate of 70 cents. Earnings were up 10% at constant exchange rate (“CER”) from the year-ago figure.